Literature DB >> 16637052

Predicting the behavior of novel sugar carriers for dry powder inhaler formulations via the use of a cohesive-adhesive force balance approach.

Jennifer C Hooton1, Matthew D Jones, Robert Price.   

Abstract

The aim of this work was to utilize the recently developed cohesive-adhesive balance (CAB) technique for analyzing quantitative AFM measurements to compare the relative forces of interaction of micronized salbutamol sulfate particles and a selection of specifically grown sugar substrates (beta cyclodextrin, lactose, raffinose, trehalose and xylitol). The interfacial behavior was subsequently related to the in-vitro delivery performance of these sugars as carrier particles in dry powder inhalation (DPI) formulations. The CAB analysis indicated that the rank order of adhesion between salbutamol sulfate and the sugars was beta cyclodextrin < lactose < trehalose < raffinose < xylitol. The beta cyclodextrin was the only substrate with which salbutamol sulfate demonstrated a greater cohesive behavior. All other sugars exhibited an adhesive dominance. In-vitro deposition performance of the salbutamol sulfate based carrier DPI formulations showed that the rank order of the fine particle fraction (FPF) was beta cyclodextrin > lactose > raffinose > trehalose > xylitol. A linear correlation (R(2) = 0.9572) was observed between the FPF and cohesive-adhesive ratios of the AFM force measurements. The observed link between CAB analysis of the interactive forces and in-vitro performance of carrier based formulations suggested a fundamental understanding of the relative balance of the various forces of interaction within a dry powder formulation may provide a critical insight into the behavior of these formulations. (c) 2006 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16637052     DOI: 10.1002/jps.20618

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Investigation into the influence of primary crystallization conditions on the mechanical properties and secondary processing behaviour of fluticasone propionate for carrier based dry powder inhaler formulations.

Authors:  Harshal A Kubavat; Jagdeep Shur; Graham Ruecroft; David Hipkiss; Robert Price
Journal:  Pharm Res       Date:  2011-12-09       Impact factor: 4.200

2.  Effect of Device Design and Formulation on the In Vitro Comparability for Multi-Unit Dose Dry Powder Inhalers.

Authors:  Jagdeep Shur; Bhawana Saluja; Sau Lee; James Tibbatts; Robert Price
Journal:  AAPS J       Date:  2015-05-09       Impact factor: 4.009

3.  An investigation into the dispersion mechanisms of ternary dry powder inhaler formulations by the quantification of interparticulate forces.

Authors:  Matthew D Jones; Jennifer C Hooton; Michelle L Dawson; Alan R Ferrie; Robert Price
Journal:  Pharm Res       Date:  2007-10-19       Impact factor: 4.200

4.  Spray freeze drying to solidify Nanosuspension of Cefixime into inhalable microparticles.

Authors:  Dorrin Mohtadi Haghighi; Homa Faghihi; Majid Darabi; Maryam Saadat Mirmoeini; Alireza Vatanara
Journal:  Daru       Date:  2022-01-08       Impact factor: 4.088

5.  Drug content effects on the dispersion performance of adhesive mixtures for inhalation.

Authors:  Floris Grasmeijer; Paul Hagedoorn; Henderik W Frijlink; Anne H de Boer
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.